Clinical significance of coagulation biomarkers in venous pressure therapy for preventing lower-extremity deep venous thromboembolism: A meta-analysis
Venous pressure therapy favorably alters coagulation and fibrinolytic biomarkers, underscoring their diagnostic value in monitoring therapeutic efficacy and thrombotic risk. These findings highlight the critical role of laboratory indices in guiding the prevention and management of VTE, supporting their integration into standardized clinical practice.
Authors
- Chunmin Li (ORCID: https://orcid.org/0000-0001-8192-7921)
- Lijin Zhang (ORCID: https://orcid.org/0000-0002-5260-9120)
- Jingrong Niu
- Hua‐Liang Ren (ORCID: https://orcid.org/0000-0003-4569-7158)
- Shuang Zhou (ORCID: https://orcid.org/0000-0001-8694-8561)
Institutions
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- Beijing Chaoyang Emergency Medical Center (CN)
Publication Details
- Journal
- Journal of Medical Biochemistry
- Published
- 2025-10-31
- DOI
- https://doi.org/10.5937/jomb0-61632
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00